NasdaqGM - Delayed Quote • USD
Immutep Limited (IMMP)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 6:48 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2015) | Next Qtr. (Mar 2016) | Current Year (2024) | Next Year (2016) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2015) | Next Qtr. (Mar 2016) | Current Year (2024) | Next Year (2016) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 1.75M | 1.75M | 1.75M | 1.44M |
| Low Estimate | -- | -- | -- | 1.08M |
| High Estimate | 3.49M | 3.49M | 3.49M | 2.42M |
| Year Ago Sales | 3.47M | 3.47M | 3.47M | 1.75M |
| Sales Growth (year/est) | -49.60% | -49.60% | -49.60% | -17.70% |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2015) | Next Qtr. (Mar 2016) | Current Year (2024) | Next Year (2016) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | -0.27 |
| 30 Days Ago | 0 | 0 | 0 | -0.27 |
| 60 Days Ago | 0 | 0 | 0 | -0.27 |
| 90 Days Ago | 0 | 0 | 0 | -0.27 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2015) | Next Qtr. (Mar 2016) | Current Year (2024) | Next Year (2016) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | IMMP | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 5.40% |
| Next Qtr. | -- | -- | -- | 10.90% |
| Current Year | -- | -- | -- | 4.50% |
| Next Year | -- | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 10.94% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Baird: Outperform to Outperform | 8/28/2023 |
| Initiated | Baird: Outperform | 8/3/2023 |
| Initiated | Baird: Outperform | 8/3/2023 |
| Maintains | Maxim Group: Buy to Buy | 5/18/2023 |
| Initiated | Ladenburg Thalmann: Buy | 8/3/2021 |
| Maintains | Maxim Group: Buy to Buy | 5/29/2018 |
Related Tickers
HOOK HOOKIPA Pharma Inc.
0.8933
+10.82%
MESO Mesoblast Limited
6.24
+1.46%
GLSI Greenwich LifeSciences, Inc.
13.12
+6.32%
SLS SELLAS Life Sciences Group, Inc.
1.4600
-3.95%
CYCC Cyclacel Pharmaceuticals, Inc.
1.5100
-5.63%
ABEO Abeona Therapeutics Inc.
3.2600
+2.19%
ZLAB Zai Lab Limited
15.91
+1.08%
PALI Palisade Bio, Inc.
6.05
-2.89%
ACET Adicet Bio, Inc.
1.6800
-7.18%
ABVC ABVC BioPharma, Inc.
1.4200
-10.69%